Hospital Universitario de Gran Canaria Doctor Negrin

Las Palmas 35010

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN), Metastatic Breast Cancer, Relapsed or Refractory Acute Myeloid Leukemia (AML)

Studies at this site

• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early
• An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) — Stopped early